Natàlia Ramos - Concepedia

Author

Natàlia Ramos

Vall d'Hebron Hospital Universitari ORCID

Also Known As

D. Garcia, J. Navarro, María Antonieta Azancot, N Ramos, N. Ramos, N. Ramos-Terrades, NICOLE ROSE RAMOS, Nao Shimada Ramos, Natalia Ramos, Natalia Ramos Terrades

117

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Vall d'Hebron Hospital Universitari Universitat Autònoma de Barcelona Research Institute Hospital 12 de Octubre Universidad Complutense de Madrid Hospital Universitario 12 De Octubre

About

Natàlia Ramos is an author at Vall d'Hebron Hospital Universitari specializing in medicine, chronic kidney disease, and nephrology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	582
2	Immunology	3	3	71
3	Clinical Immunology	1	1	32
4	Emergency Medicine	1	1	88
5	Hepatology	1	1	27

Natàlia Ramos

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink, The Lancet	2023	224
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers, The Lancet GlomerulonephritisActive-controlled Clinical TrialRenal FunctionKidney FailureChronic Kidney Disease	2023	203
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial Katherine R. Tuttle, Sibylle J. Hauske, María Eugênia Fernandes Canziani, The Lancet HypertensionRenal FunctionRenal DiseaseMedicineKidney Failure	2023	151
Rituximab Treatment of Adult Patients with Steroid-Resistant Focal Segmental Glomerulosclerosis Gema Fernández‐Fresnedo, Alfonso Segarra, Ester González, Clinical Journal of the American Society of Nephrology	2009	124
Successful Treatment of Membranous Glomerulonephritis with Rituximab in Calcineurin Inhibitor-Dependent Patients Alfons Segarra, Manuel Praga, Natàlia Ramos, Clinical Journal of the American Society of Nephrology	2009	92
Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome Teresa Cavero, Emilia Arjona, Karina Soto, Kidney International HypertensionUrologyHemodialysisMedicineKidney Failure	2019	88
Mycophenolate Mofetil in C3 Glomerulopathy and Pathogenic Drivers of the Disease Fernando Caravaca‐Fontán, Montserrat M. Díaz Encarnación, Laura Lucientes, Clinical Journal of the American Society of Nephrology	2020	73
Predictors of response and relapse in patients with idiopathic membranous nephropathy treated with tacrolimus J. Caro, E. Gutiérrez-Solís, Jorge Rojas-Rivera, Nephrology Dialysis Transplantation	2014	64
Efficacy and safety of bortezomib in refractory lupus nephritis: a single-center experience A. Segarra, Karla Arredondo, Juan Felipe Espitia Jaramillo, Lupus	2019	63
Mesangial C4d Deposits in Early IgA Nephropathy Alfons Segarra, Katheryne Romero, Irene Agraz, Clinical Journal of the American Society of Nephrology	2017	61

Page 1